Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds

被引：40

作者：

Cuenca-Estrella, Manuel ^{[1
]}

Gomez-Lopez, Alicia ^{[1
]}

Mellado, Emilia ^{[1
]}

Monzon, Araceli ^{[1
]}

Buitrago, Maria J. ^{[1
]}

Rodriguez-Tudela, Juan L. ^{[1
]}

机构：

[1] Inst Salud Carlos III, Dept Mycol, Spanish Natl Ctr Microbiol, Madrid 28220, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 05期

关键词：

ANTIFUNGAL SUSCEPTIBILITY; GLOBAL SURVEILLANCE; EUROPEAN COMMITTEE; FILAMENTOUS FUNGI; CANDIDA-ALBICANS; CASPOFUNGIN; ANIDULAFUNGIN; ASPERGILLUS; VORICONAZOLE; AGENTS;

D O I：

10.1128/AAC.01543-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A collection of 2,278 isolates belonging to 86 different fungal species was tested with micafungin and eight other drugs using the EUCAST procedures. Micafungin was active against species of Candida and Aspergillus (even azole-resistant species) as well as Penicillium spp., Scedosporium apiospermum, and Acremonium spp. It was inactive for species of Basidiomycota and Mucorales and for multiresistant species such as those of Fusarium.

引用

页码：2192 / 2195

页数：4

共 22 条

[11] Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin:: Analysis and proposal for interpretive MIC breakpoints [J].

Pfaller, M. A. ;

Diekema, D. J. ;

Ostrosky-Zeichner, L. ;

Rex, J. H. ;

Alexander, B. D. ;

Andes, D. ;

Brown, S. D. ;

Chaturvedi, V. ;

Ghannoum, M. A. ;

Knapp, C. C. ;

Sheehan, D. J. ;

Walsh, T. J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (08) :2620-2629

[12] Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis:: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 [J].

Pfaller, M. A. ;

Diekema, D. J. ;

Gibbs, D. L. ;

Newell, V. A. ;

Ng, K. P. ;

Colombo, A. ;

Finquelievich, J. ;

Barnes, R. ;

Wadula, J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) :842-849

[13] In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin:: Six years of global surveillance [J].

Pfaller, M. A. ;

Boyken, L. ;

Hollis, R. J. ;

Kroeger, J. ;

Messer, S. A. ;

Tendolkar, S. ;

Diekema, D. J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) :150-156

[14] Global surveillance of in vitro activity of micafungin against Candida:: a comparison with caspofungin by CLSI-recommended methods [J].

Pfaller, M. A. ;

Boyken, L. ;

Hollis, R. J. ;

Messer, S. A. ;

Tendolkar, S. ;

Diekema, D. J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (10) :3533-3538

[15] Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis [J].

Rautemaa, Riina ;

Richardson, Malcolm ;

Pfaller, Michael A. ;

Perheentupa, Jaakko ;

Saxen, Harri .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (02) :182-185

[16] Micafungin activity against Candida albicans with diverse azole resistance phenotypes [J].

Richards, Theresa S. ;

Oliver, Brian G. ;

White, Theodore C. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (02) :349-355

[17] EUCAST Technical Note on voriconazole - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST) [J].

Rodriguez-Tudela, J. L. ;

Donnelly, J. P. ;

Arendrup, M. C. ;

Arikan, S. ;

Barchiesi, F. ;

Bille, J. ;

Chryssanthou, E. ;

Cuenca-Estrella, M. ;

Dannaoui, E. ;

Denning, D. ;

Fegeler, W. ;

Gaustad, P. ;

Lass-Flori, C. ;

Moore, C. ;

Richardson, M. ;

Schmalreck, A. ;

Velegraki, J. A. ;

Verweij, P. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (10) :985-987

[18] EUCAST Definitive Document EDef 7.1:: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts [J].

Rodriguez-Tudela, J. L. ;

Arendrup, M. C. ;

Barchiesi, F. ;

Bille, J. ;

Chryssanthou, E. ;

Cuenca-Estrella, M. ;

Dannaoui, E. ;

Denning, D. W. ;

Donnelly, J. P. ;

Dromer, F. ;

Fegeler, W. ;

Lass-Floerl, C. ;

Moore, C. ;

Richardson, M. ;

Sandven, P. ;

Velegraki, A. ;

Verweij, P. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (04) :398-405

[19] National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin [J].

Takakura, S ;

Fujihara, N ;

Saito, T ;

Kudo, T ;

Iinuma, Y ;

Ichiyama, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) :283-289

[20] EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST) [J].

Tudela, J. -L. Rodriquez ;

Donnelly, J. P. ;

Arendrup, M. C. ;

Arikan, S. ;

Barchiesi, F. ;

Bille, J. ;

Chryssanthou, E. ;

Cuenca-Estrella, M. ;

Dannaoui, E. ;

Denning, D. ;

Fegeler, W. ;

Gaustad, P. ;

Lass-Florl, C. ;

Moore, C. ;

Richardson, M. ;

Schmalreck, A. ;

Velegraki, J. A. ;

Verweij, P. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (10) :982-984

← 1 2 3 →